Research programme: apolipoprotein A1 - BioDelivery Sciences

Drug Profile

Research programme: apolipoprotein A1 - BioDelivery Sciences

Alternative Names: Apolipoprotein A1 research programme - BioDelivery Sciences

Latest Information Update: 11 Apr 2007

Price : $50

At a glance

  • Originator BioDelivery Sciences International
  • Class
  • Mechanism of Action Apolipoprotein A I stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Atherosclerosis

Most Recent Events

  • 20 Apr 2004 Preclinical trials in Atherosclerosis in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top